Our therapy areas
Unlocking the power of what science can do
The path to new treatments
The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following: Oncology; BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology); and Rare Disease.
An exciting pipeline
Our pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development.
199
projects in our pipeline
21
new molecular entities in our late-stage pipeline
3
new molecular entities under review
What science can do
Our purpose is to push the boundaries of science to deliver life-changing medicines